坦昔妥单抗联合来那度胺在澳门获批用于治疗复发/难治性弥漫性大B细胞淋巴瘤_老虎社区_美港股上老虎

坦昔妥单抗联合来那度胺在澳门获批用于治疗复发/难治性弥漫性大B细胞淋巴瘤

诺诚健华（上交所代码：688428；香港联交所代码：09969）今天宣布，坦昔妥单抗联合来那度胺在澳门获批用于治疗复发/难治性弥漫性大B细胞淋巴瘤。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":390185322062272,"tweetId":"390185322062272","gmtCreate":1736304091360,"gmtModify":1736304094011,"author":{"id":4136424236874470,"idStr":"4136424236874470","authorId":4136424236874470,"authorIdStr":"4136424236874470","name":"动态宝","avatar":"https://static.tigerbbs.com/e62b318cef034036fd668b3a75bbaa6e","vip":5,"userType":5,"introduction":"企业动态信息智能分发平台","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":153,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"坦昔妥单抗联合来那度胺在澳门获批用于治疗复发/难治性弥漫性大B细胞淋巴瘤","html":"<html><head></head><body>诺诚健华（上交所代码：688428；香港联交所代码：09969）今天宣布，坦昔妥单抗联合来那度胺在澳门获批用于治疗复发/难治性弥漫性大B细胞淋巴瘤。\n\n</body></html>","htmlText":"<html><head></head><body>诺诚健华（上交所代码：688428；香港联交所代码：09969）今天宣布，坦昔妥单抗联合来那度胺在澳门获批用于治疗复发/难治性弥漫性大B细胞淋巴瘤。\n\n</body></html>","text":"诺诚健华（上交所代码：688428；香港联交所代码：09969）今天宣布，坦昔妥单抗联合来那度胺在澳门获批用于治疗复发/难治性弥漫性大B细胞淋巴瘤。","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/390185322062272","repostId":0,"isVote":1,"tweetType":1,"viewCount":24673,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["09969","688428"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":128,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}